Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Johnson and Johnson
Medtronic
McKinsey
Mallinckrodt

Last Updated: June 27, 2022

PROPRANOLOL HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Propranolol Hydrochloride, and what generic alternatives are available?

Propranolol Hydrochloride is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Amta, Inwood Labs, Mylan, Nortec Dev Assoc, Upsher Smith Labs, Zydus Pharms Usa Inc, Baxter Hlthcare Corp, Chartwell Injectable, Fosun Pharma, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Hikma, Pai Holdings Pharm, Ani Pharms, Chartwell Rx, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Northstar Hlthcare, Purepac Pharm, Roxane, Sandoz, Schering, Strides Pharma, Superpharm, Teva, Vintage Pharms, Warner Chilcott, Watson Labs, and Watson Labs Teva. and is included in one hundred and thirty-seven NDAs.

The generic ingredient in PROPRANOLOL HYDROCHLORIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.

Summary for PROPRANOLOL HYDROCHLORIDE
Drug patent expirations by year for PROPRANOLOL HYDROCHLORIDE
Recent Clinical Trials for PROPRANOLOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tianjin Medical University General HospitalPhase 2
Roswell Park Cancer InstituteN/A
Iqvia Pty LtdPhase 1

See all PROPRANOLOL HYDROCHLORIDE clinical trials

Pharmacology for PROPRANOLOL HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PROPRANOLOL HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PROPRANOLOL HYDROCHLORIDE

US Patents and Regulatory Information for PROPRANOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Innogenix PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070322-005 Sep 24, 1986 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Northstar Hlthcare PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 078213-004 Jan 10, 2008 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hikma PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride SOLUTION;ORAL 070979-001 May 15, 1987 RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Zydus Pharms Usa Inc PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 090321-004 Mar 25, 2011 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Actavis Elizabeth PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070852-001 May 15, 1986 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Watson Labs PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070382-001 Mar 19, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ivax Sub Teva Pharms PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 072068-001 Jul 29, 1988 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Johnson and Johnson
Mallinckrodt
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.